The natural course and factors affecting severity of Behçet’s disease: a single-center cohort of 368 patients

Rheumatology International

Volumn 35, Issue 12, 2015, Pages 2103-2107

  Ugurlu, Nilay ^a   Bozkurt, Selen ^a   Bacanli, Ali ^b   Akman Karakas, Ayse ^a   Uzun, Soner ^a   Alpsoy, Erkan ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Antalya Education and Research Hospital   (Turkey)

Author keywords

Beh et s disease; Chronology; Course; Onset manifestation; Severity; Symptom

Indexed keywords

ADULT; AGED; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ERYTHEMA NODOSUM; EYE DISEASE; FEMALE; GENITAL ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; ONSET AGE; PRIORITY JOURNAL; PUSTULE; RETROSPECTIVE STUDY; RISK FACTOR; SYMPTOMATOLOGY; BEHCET SYNDROME; COMPLICATION; MIDDLE AGED; ORAL ULCER; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

ADULT; BEHCET SYNDROME; DISEASE PROGRESSION; ERYTHEMA NODOSUM; FEMALE; HUMANS; MALE; MIDDLE AGED; ORAL ULCER; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SYMPTOM ASSESSMENT;

EID: 84947615469     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-015-3310-5     Document Type: Article

References (25)

1. Alpsoy E, Kodelja V, Goerdt S et al (2003) Serum of patients with Behçet’s disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 206:225–232
2. Yazici H, Tuzun Y, Pazarli H et al (1984) Influence of age of onset and patient’s sex on the prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43:783–789
3. Zouboulis CC, Vaiopoulos G, Marcomichelakis N et al (2003) Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades–Behcet’s disease in Greece. Clin Exp Rheumatol 21(4 Suppl 30):S19–S26
4. Kural-Seyahi E, Fresko I, Seyahi N et al (2003) The long-term mortality and morbidity of Behcet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 82:60–76
5. International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080
6. Krause I, Mader R, Sulkes J et al (2001) Behçet’s disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 28:1033–1036
7. Cho SB, Cho S, Bang D (2012) New insights in the clinical understanding of Behçet’s disease. Yonsei Med J 53:35–42
8. Vaiopoulos G, Konstantopoulou P, Evangelatos N et al (2010) The spectrum of mucocutaneous manifestations in Adamantiades–Behçet’s disease in Greece. J Eur Acad Dermatol Venereol 24:434–438
9. El Menyawi MM, Raslan HM, Edrees A (2009) Clinical features of Behcet’s disease in Egypt. Rheumatol Int 29:641–646
10. Pipitone N, Boiardi L, Olivieri I et al (2004) Clinical manifestations of Behçet’s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 22(6 Suppl 36):S46–S51
11. Salvarani C, Pipitone N, Catanoso MG et al (2007) Epidemiology and clinical course of Behçet’s disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. Arthritis Rheum 57:171–178
12. Shafie N, Shahram F, Nadji A et al (1997) Iran’s aspects of Behçet’s disease in children. The 1996 survey. In: Hamsa M (ed) Behçet’s disease. Pub Adhoua, Tunis, pp 125–129
13. Krause I, Uziel Y, Guedj D et al (1998) Mode of presentation and multisystem involvement in Behçet’s disease: the influence of sex and age of disease onset. J Rheumatol 25:1566–1569
14. Ideguchi H, Suda A, Takeno M et al (2011) Behçet disease: evolution of clinical manifestations. Medicine (Baltimore) 90:125–132
15. Wang LY, Zhao DB, Gu J et al (2010) Clinical characteristics of Behçet’s disease in China. Rheumatol Int 30:1191–1196
16. Zhang Z, He F, Shi Y (2013) Behcet’s disease seen in China: analysis of 334 cases. Rheumatol Int 33:645–648
17. Alpsoy E, Donmez L, Bacanli A et al (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207:354–356
18. Alpsoy E, Donmez L, Onder M et al (2007) Clinical features and natural course of Behçet’s disease in 661 cases: a multicentre study. Br J Dermatol 157:901–906
19. Sachetto Z, Mahayri N, Ferraz RH et al (2012) Behçet’s disease in Brazilian patients: demographic and clinical features. Rheumatol Int 32:2063–2067
20. Koç Y, Güllü I, Akpek G et al (1992) Vascular involvement in Behcet’s disease. J Rheumatol 19:402–410
21. Yazici H, Tüzün Y, Tanman AB et al (1985) Male patients with Behçet’s syndrome have stronger pathergy reactions. Clin Exp Rheumatol 3:137–141
22. Chang HK, Cheon KS (2002) The clinical significance of a pathergy reaction in patients with Behcet’s disease. J Korean Med Sci 17:371–374
23. Bonitsis NG, Luong Nguyen LB, LaValley MP et al (2015) Gender-specific differences in Adamantiades–Behçet’s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature. Rheumatology (Oxford) 54:121–133
24. Bang DS, Oh SH, Lee KH et al (2003) Influence of sex on patients with Behcet’s disease in Korea. J Korean Med Sci 18:231–235
25. Alli N, Gur G, Yalcin B et al (2009) Patient characteristics in Behçet disease: a retrospective analysis of 213 Turkish patients during 2001–4. Am J Clin Dermatol 10:411–418